LA
VVOS icon

Latitude Advisors’s Vivos Therapeutics VVOS Stock Holding History

Latitude Advisors’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15 Buy
+104
New +$31 ﹤0.01% 1376

Other funds holding VVOS

Centurion Wealth Management
Centurion Wealth Management Mclean, Virginia $415M AUM 17.23% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
Acorn Wealth Advisors
Acorn Wealth Advisors Grand Blanc, Michigan $407M AUM 14.44% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Latitude Advisors's VVOS Position: Q3 2026 in Review

Latitude Advisors opened a new position in Vivos Therapeutics (VVOS) in Q3 2026: 104 shares worth $15. The stake represents ﹤0.01% of the portfolio and ranks #1376 among its holdings.

7 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

  • Latitude Advisors held 104 shares of Vivos Therapeutics worth $15 as of Q3 2026.
  • Vivos Therapeutics was a new Latitude Advisors position in Q3 2026.
  • Vivos Therapeutics made up ﹤0.01% of Latitude Advisors's portfolio in Q3 2026, its #1376 holding.
  • 7 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on Latitude Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.